303 related articles for article (PubMed ID: 19652884)
1. Effects of the cAMP-elevating agents cilostamide, cilostazol and forskolin on the phosphorylation of Akt and GSK-3beta in platelets.
Hayashi H; Sudo T
Thromb Haemost; 2009 Aug; 102(2):327-35. PubMed ID: 19652884
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets.
Sudo T; Ito H; Kimura Y
Platelets; 2003 Sep; 14(6):381-90. PubMed ID: 14602552
[TBL] [Abstract][Full Text] [Related]
3. Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta.
Li M; Wang X; Meintzer MK; Laessig T; Birnbaum MJ; Heidenreich KA
Mol Cell Biol; 2000 Dec; 20(24):9356-63. PubMed ID: 11094086
[TBL] [Abstract][Full Text] [Related]
4. GSK-3beta regulation in skeletal muscles by adrenaline and insulin: evidence that PKA and PKB regulate different pools of GSK-3.
Jensen J; Brennesvik EO; Lai YC; Shepherd PR
Cell Signal; 2007 Jan; 19(1):204-10. PubMed ID: 16934435
[TBL] [Abstract][Full Text] [Related]
5. The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents.
Russo I; Doronzo G; Mattiello L; De Salve A; Trovati M; Anfossi G
Thromb Res; 2004; 114(4):265-73. PubMed ID: 15381390
[TBL] [Abstract][Full Text] [Related]
6. Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism.
Hashimoto A; Miyakoda G; Hirose Y; Mori T
Atherosclerosis; 2006 Dec; 189(2):350-7. PubMed ID: 16545819
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of platelet aggregation by the cAMP-phosphodiesterase inhibitor, cilostamide, may not be associated with activation of cAMP-dependent protein kinase.
Nishikawa M; Komada F; Morita K; Deguchi K; Shirakawa S
Cell Signal; 1992 Jul; 4(4):453-63. PubMed ID: 1329900
[TBL] [Abstract][Full Text] [Related]
8. ADP-stimulated activation of Akt during integrin outside-in signaling promotes platelet spreading by inhibiting glycogen synthase kinase-3β.
O'Brien KA; Gartner TK; Hay N; Du X
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2232-40. PubMed ID: 22814751
[TBL] [Abstract][Full Text] [Related]
9. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet action of indirubin-3'-monoxime through suppression of glycoprotein VI-mediated signal transduction: a possible role for ERK signaling in platelets.
Lee JJ; Han JH; Jung SH; Lee SG; Kim IS; Cuong NM; Huong TT; Khanh PN; Kim YH; Yun YP; Ma JY; Myung CS
Vascul Pharmacol; 2014 Dec; 63(3):182-92. PubMed ID: 25451564
[TBL] [Abstract][Full Text] [Related]
11. The cAMP effectors PKA and Epac activate endothelial NO synthase through PI3K/Akt pathway in human endothelial cells.
García-Morales V; Luaces-Regueira M; Campos-Toimil M
Biochem Pharmacol; 2017 Dec; 145():94-101. PubMed ID: 28912066
[TBL] [Abstract][Full Text] [Related]
12. Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei.
Salas TR; Reddy SA; Clifford JL; Davis RJ; Kikuchi A; Lippman SM; Menter DG
J Biol Chem; 2003 Oct; 278(42):41338-46. PubMed ID: 12900420
[TBL] [Abstract][Full Text] [Related]
13. Coordinate regulation of forskolin-induced cellular proliferation in macrophages by protein kinase A/cAMP-response element-binding protein (CREB) and Epac1-Rap1 signaling: effects of silencing CREB gene expression on Akt activation.
Misra UK; Pizzo SV
J Biol Chem; 2005 Nov; 280(46):38276-89. PubMed ID: 16172130
[TBL] [Abstract][Full Text] [Related]
14. Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma.
Khor TO; Gul YA; Ithnin H; Seow HF
Cancer Lett; 2004 Jul; 210(2):139-50. PubMed ID: 15183529
[TBL] [Abstract][Full Text] [Related]
15. Dissociation between the translocation and the activation of Akt in fMLP-stimulated human neutrophils--effect of prostaglandin E2.
Burelout C; Naccache PH; Bourgoin SG
J Leukoc Biol; 2007 Jun; 81(6):1523-34. PubMed ID: 17339610
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
17. Signaling pathways mediating phosphorylation and inactivation of glycogen synthase kinase-3β by the recombinant human δ-opioid receptor stably expressed in Chinese hamster ovary cells.
Olianas MC; Dedoni S; Onali P
Neuropharmacology; 2011 Jun; 60(7-8):1326-36. PubMed ID: 21276805
[TBL] [Abstract][Full Text] [Related]
18. Escitalopram Ameliorates Tau Hyperphosphorylation and Spatial Memory Deficits Induced by Protein Kinase A Activation in Sprague Dawley Rats.
Ren QG; Wang YJ; Gong WG; Xu L; Zhang ZJ
J Alzheimers Dis; 2015; 47(1):61-71. PubMed ID: 26402755
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of the guanine-nucleotide-exchange factor CalDAG-GEFI by protein kinase A regulates Ca(2+)-dependent activation of platelet Rap1b GTPase.
Guidetti GF; Manganaro D; Consonni A; Canobbio I; Balduini C; Torti M
Biochem J; 2013 Jul; 453(1):115-23. PubMed ID: 23600630
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase.
Filippa N; Sable CL; Filloux C; Hemmings B; Van Obberghen E
Mol Cell Biol; 1999 Jul; 19(7):4989-5000. PubMed ID: 10373549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
